- The stock price of Oragenics Inc (NYSEAMERICAN: OGEN) increased by over 20% pre-market today. This is why it happened.
The stock price of Oragenics Inc (NYSEAMERICAN: OGEN) increased by over 20% pre-market today. Investors appear to be responding positively to a Form 4 filing.
The Form 4 filing shows that company director Robert Koski acquired a couple of large positions in the company. The transactions include:
— 200,900 shares acquired at an average price of $0.4498 each
— 799,100 shares acquired at an average price of $0.474 each
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.
